Loading clinical trials...
Loading clinical trials...
During normal physiological conditions hemostasis (the ability of blood to clot) is kept in homeostatic balance by feedback mechanisms. These mechanisms involve an extremely complex series of steps on...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Haemonetics Corporation
NCT05156983 · Coagulation Disorder
NCT06403163 · Transfusion Reaction, Transfusion Related Complication, and more
NCT07024160 · Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
NCT06429787 · Vitamin K-Dependent Coagulation Defect, Significant Bleeding Risk
NCT00178594 · Blood Coagulation Disorders, Inherited, Thrombotic Disorder
Sinai Center for Thrombosis Research
Baltimore, Maryland
Univserity of Tennessee Health Sciences Center
Knoxville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions